Qige San regulates paclitaxel resistance in esophageal cancer by targeting ferroptosis

Figure 1 Qige San regulated paclitaxel resistance in esophageal cancer. A: The viability of TE-1/paclitaxel (PTX) and EC109/PTX and parental cancer cells treated with PTX; B: Viability of TE-1/PTX and EC109/PTX cells that treated with PTX and Qige San (QG); C: Proliferation of TE-1/PTX and EC109/PTX cells that treated with PTX and QG; D: Migration of TE-1/PTX and EC109/PTX cells that treated with PTX and QG. Data are mean ± standard error of the mean (n = 3). ^aP < 0.05; ^cP < 0.001 vs control; ^fP < 0.001 vs QG (one-way analysis of variance with Tukey’s test); QG: Qige San; PTX: Paclitaxel; Cont: Control.